- All sections
- C - Chemistry; metallurgy
- C12N - Microorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture media
- C12N 9/52 - Proteinases derived from bacteria
Patent holdings for IPC class C12N 9/52
Total number of patents in this class: 1015
10-year publication summary
|
77
|
90
|
87
|
88
|
94
|
87
|
81
|
84
|
77
|
28
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Novozymes A/S | 3314 |
77 |
| President and Fellows of Harvard College | 5792 |
46 |
| Allergan, Inc. | 2600 |
33 |
| Ipsen Biopharm Limited | 263 |
20 |
| Ipsen Bioinnovation Limited | 57 |
19 |
| The Broad Institute, Inc. | 1584 |
17 |
| The Regents of the University of California | 18943 |
16 |
| Massachusetts Institute of Technology | 9795 |
16 |
| MERZ PHARMA GmbH & CO. KGaA | 624 |
14 |
| Hoffmann-La Roche Inc. | 3060 |
13 |
| University of Washington | 2157 |
13 |
| Children's Medical Center Corporation | 1780 |
12 |
| ContraFect Corporation | 91 |
12 |
| F. Hoffmann-La Roche AG | 7958 |
11 |
| Danisco US Inc. | 1045 |
11 |
| Amano Enzyme Inc. | 324 |
10 |
| Board of Trustees of the University of Arkansas | 771 |
10 |
| HANSA Biopharma AB | 67 |
10 |
| Biomadison, Inc. | 48 |
9 |
| Lysando AG | 50 |
9 |
| Other owners | 637 |